Eudaimonia Advisors LLC Has $936,000 Stock Position in CME Group Inc. (NASDAQ:CME)

Eudaimonia Advisors LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 4,443 shares of the financial services provider’s stock after acquiring an additional 75 shares during the quarter. Eudaimonia Advisors LLC’s holdings in CME Group were worth $936,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently bought and sold shares of the company. AE Wealth Management LLC raised its holdings in CME Group by 25.5% during the 3rd quarter. AE Wealth Management LLC now owns 2,543 shares of the financial services provider’s stock worth $509,000 after purchasing an additional 516 shares during the last quarter. Arkadios Wealth Advisors acquired a new position in CME Group during the 3rd quarter worth approximately $261,000. Global Retirement Partners LLC raised its stake in shares of CME Group by 7.7% during the 3rd quarter. Global Retirement Partners LLC now owns 2,354 shares of the financial services provider’s stock worth $478,000 after purchasing an additional 168 shares in the last quarter. Naples Global Advisors LLC raised its stake in shares of CME Group by 5.4% during the 3rd quarter. Naples Global Advisors LLC now owns 1,962 shares of the financial services provider’s stock worth $393,000 after purchasing an additional 100 shares in the last quarter. Finally, Essex LLC bought a new stake in shares of CME Group during the 3rd quarter worth approximately $385,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Trading Up 0.6 %

CME Group stock traded up $1.29 during trading hours on Tuesday, hitting $216.77. The stock had a trading volume of 2,048,251 shares, compared to its average volume of 1,779,931. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $78.04 billion, a price-to-earnings ratio of 24.44, a P/E/G ratio of 6.04 and a beta of 0.49. CME Group Inc. has a one year low of $175.73 and a one year high of $223.80. The business’s 50 day simple moving average is $214.59 and its 200-day simple moving average is $211.89.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, beating the consensus estimate of $2.27 by $0.10. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The business’s quarterly revenue was up 19.2% on a year-over-year basis. During the same period last year, the company earned $1.92 earnings per share. On average, equities analysts predict that CME Group Inc. will post 9.57 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.12%. This is an increase from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend was Thursday, March 7th. CME Group’s dividend payout ratio (DPR) is 51.86%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a research note on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $210.00 target price (down from $235.00) on shares of CME Group in a report on Friday, April 5th. Barclays increased their target price on CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a report on Monday, April 8th. Argus raised their price objective on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Finally, Keefe, Bruyette & Woods reaffirmed a “market perform” rating and issued a $229.00 price objective on shares of CME Group in a research note on Wednesday, April 3rd. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $215.70.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.